RB1 and neoplasm: Similarly, an increase in TP53 and Rb1 mRNA expression was observed in both cell lines following treatment with EPZ6438 and ZLD1039, while cisplatin-treated cells displayed a decrease for both tumour suppressors (Figure 6C).